Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan in Dilutional Hyponatremia (DILIPO)
NCT00274326Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 3, randomised, double-blind trial in Dilutional hyponatremia (DH) comparing Satavaptan with Placebo (2 arms). Primary endpoint: Serum Sodium Concentration. Started May 2005; status: completed.
02
Drugs
satavaptan
03
Conditions
Dilutional hyponatremia (DH)
Beyond the preview
Go deeper on NCT00274326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274326.